Moderna’s stock doubles on promising cancer-vaccine results
MarketWatch· Jaimy Lee· Aug 19, 2026 · 12:15 PM
The vaccine candidate pairs an mRNA therapy with the cancer drug Keytruda.
This is a summary. Read the complete story at MarketWatch below.
Read full article at MarketWatchRelated Stories
markets18 minutes ago
SpaceX sends its Starship rocket to orbit for the first time
The company is getting closer to making the rocket fully reusable.
MarketWatch
markets18 minutes ago
‘I’m never selling’: I’m 47 and buy bitcoin with every dollar I earn. Am I crazy?
“When my paycheck lands, it takes a detour through bitcoin.”
MarketWatch
markets32 minutes ago
MongoDB’s stock is down more than 20% as CEO decamps to Meta
Meta is creating an enterprise platform business that aims to make it easier for developers to use its products. CJ Desai, formerly of MongoDB, will head up the initiative.
MarketWatch